A Safety Study of ARRY-403 in Patients With Type 2 Diabetes
Clinical trial NCT00952198 · COMPLETED
Trial details
- NCT number
- NCT00952198
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.